Tgs
Payments companies reported to CMS as associated with Tgs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tgs, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tgs
These are the largest totals companies reported as associated with Tgs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jared Knopman | New York, NY | Neurological Surgery | $20,800.00 |
| Satoshi Tateshima | Los Angeles, CA | Vascular & Interventional Radiology | $19,587.33 |
| Matthew Fiesta | Fort Worth, TX | Diagnostic Radiology | $19,106.30 |
| Michelle Smith | Paoli, PA | Neurological Surgery | $17,209.16 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $11,700.00 |
| Alexander Coon | Baltimore, MD | Neurological Surgery | $11,446.82 |
| Demetrius Lopes | Park Ridge, IL | Neurological Surgery | $9,600.00 |
| Guilherme Dabus | Miami, FL | Neuroradiology | $6,034.88 |
| Arjun Pendharkar | Redwood City, CA | Neurological Surgery | $4,500.00 |
| Nicholas Telischak | Stanford, CA | Neuroradiology | $4,288.05 |
Prescribed Tgs?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.